PharmaCann International
Grow Group UK
About Herijuana
HerIndica HybridA descendant of a 🇺🇸 Humboldt County strain called Petrolia Headstash, an Indica of 🇦🇫 Afghani origins and a Kentucky landrace hybrid.
American Bred, 
Afghani Genetics
Herijuana is a descendant of a Humboldt County strain called Petrolia Headstash, an Indica of Afghani origins and a Kentucky landrace hybrid (possibly Killer New Haven).
In 2006, Sannie of Sannie's seeds inherited Herijuana, also called Herojuana, from Motarebel when the breeder had to take a hiatus from growing. Motarebel had acquired Herijuana from Woodhorse Seeds and had carefully tweaked the strain to perfection. Sannie and Motarebel often traded and worked on genetics together, so it was only natural for him to take the temporarily orphaned strain.
In 2019 Cory Peak Inc, a Californian producer, cultivated Herijuana that was 32.19% THC. It may be thought-provoking and meditative, and it can alleviate stress and anxiety. This strain may help regulate mood disorders, including chronic depression. The numbing effect on the body relieves pain and eases muscle twitches and spasms. Herijuana may also help with ADD/ADHD, migraines, and arthritis. Eventually, its sedative effects can put users into a deep sleep.
Description provided by Wikileaf.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About PhCann International B.V.
PharmaCann International is a leading company in the field of pharmaceutical cannabis, operating in accordance with EU GMP standards, with vertically integrated operations including, cloning, cultivating, cannabinoid API extraction, and pharmaceutical production and packaging.
Since inception, PharmaCann International has strive in its corporate social responsibility strategy to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids.
PharmaCann’s mission is make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, at the right cost and for the right indication. Quality Control
PharmaCann operates in accordance with the highest standards, including GACP, GLP, GDP and ISO 9001, ISO 14001, ISO 27001 ISO 17025. and has a world-class laboratory for testing cannabinoids and research and development.
The Company’s European pharmaceutical cannabis facility has incorporated the latest growing, extraction and packaging technology as well established scientific methodologies to develop targeted medical cannabis products.
nyskholdings.com
Further National Health-Service Information on